ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Chiasma Inc

Chiasma Inc (CHMA)

3.76
0.00
(0.00%)
Closed September 20 4:00PM
3.76
0.00
( 0.00% )
Pre Market: 8:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
3.76
Bid
3.76
Ask
3.80
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
3.76
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CHMA Latest News

Pulmatrix appoints Director Anand Varadan

Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass., July 27, 2021 LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc. PR Newswire NEW YORK, May 5, 2021 NEW YORK, May 5, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential...

Chiasma Announces Pricing of a Public Offering of $70 Million of Common Stock and Pre-Funded Warrants

NEEDHAM, Mass., July 01, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its...

Chiasma Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

NEEDHAM, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its...

Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog

MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide Conference call and webcast scheduled...

Chiasma Reports First Quarter 2020 Financial Results

NEEDHAM, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients who face challenges...

Chiasma To Report First Quarter Financial Results On May 7, 2020

NEEDHAM, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare and serious...

Chiasma Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

NEEDHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late stage biopharmaceutical company focused on improving the lives of patients who face challenges...

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

NEEDHAM, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare and serious...

Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results

MYCAPSSA® PDUFA Date Set for June 26, 2020; U.S. Commercial Launch Planned in Q4’20 First Industry Sponsored U.S. Disease State Registry for Acromegaly Began Enrolling Patients NEEDHAM, Mass...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVVENuvve Holding Corporation
$ 7.10
(81.12%)
2.37M
SOXMTradr 2X Long SOXX Monthly ETF
$ 36.96
(58.98%)
48
NUKKNukkleus Inc
$ 0.3271
(53.93%)
16.02M
LGHLWLion Group Holding Ltd
$ 0.008
(33.33%)
12
SPPLSIMPPLE Ltd
$ 0.48
(31.51%)
1
ZJYLJin Medical International Ltd
$ 3.00
(-26.47%)
36.25k
PRFXPainReform Ltd
$ 0.58
(-24.78%)
18.82k
SMXTSolarMax Technology Inc
$ 0.7029
(-19.75%)
214
CJETChijet Motor Company Inc
$ 2.28
(-18.57%)
793
ADTXAditxt Inc
$ 0.315
(-17.67%)
68.51k
NUKKNukkleus Inc
$ 0.3271
(53.93%)
16.02M
LGCBLinkage Global Inc
$ 0.5295
(26.58%)
11.44M
MAXNMaxeon Solar Technologies Ltd
$ 0.0787
(-13.99%)
3.55M
GSIWGarden Stage Ltd
$ 1.67
(24.63%)
3.28M
NVVENuvve Holding Corporation
$ 7.10
(81.12%)
2.37M

CHMA Discussion

View Posts
ClayTrader ClayTrader 3 years ago
* * $CHMA Video Chart 05-05-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
swampboots swampboots 3 years ago
Fool was right!
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
I saw some fool MM pushing this on twitter! lolzzzzzz
👍️0
Xzibit Xzibit 4 years ago
CHMA - Insider Buying
👍️0
whytestocks whytestocks 4 years ago
Breaking News: $CHMA Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly

NEEDHAM, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company utilizing its delivery platform technology to develop oral therapies to reduce the burden of chronic injections for people with rare diseases, today announced the com...

Read the whole news CHMA - Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly
👍️0
Tempy Tempy 4 years ago
Great news after the bell...time to move on up, to the top!!!
👍️0
Tempy Tempy 4 years ago
Nice day here...let’s see if it continues.
👍️0
blue finch blue finch 4 years ago
Lots of potential here

👍️0
#NeverPennyLand #NeverPennyLand 5 years ago
Reversal imminent imo
👍️0
ClayTrader ClayTrader 5 years ago
* * $CHMA Video Chart 07-23-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
JohnConnor67 JohnConnor67 5 years ago
Market Movers, July.23rd! Some light DD included for CHMA also!
Cheers!

https://interactiveswingtrading.com/2019/07/23/market-movers-july-23rd/
👍️0
stock1ace1 stock1ace1 5 years ago
Grabbed 8s
👍️0
whytestocks whytestocks 5 years ago
News: $CHMA Chiasma Announces Positive Phase 3 Top-Line Results from CHIASMA OPTIMAL Clinical Trial of Mycapssa® for the Maintenance Treatment of Adults with Acromegaly

SPA-agreed trial met primary and all secondary endpoints No new or unexpected safety signals in the Mycapssa treated patients 90% of the patients treated with Mycapssa who completed the 36-week study opted to continue into the Open Label Extension Company to host conference ca...

In case you are interested Chiasma Announces Positive Phase 3 Top-Line Results from CHIASMA OPTIMAL Clinical Trial of Mycapssa® for the Maintenance Treatment of Adults with Acromegaly
👍️0
europtiger europtiger 5 years ago
Got 8,10s

Stop 7,10
👍️0
europtiger europtiger 5 years ago
Buying 8,20,s
👍️0
behindthebid behindthebid 5 years ago
Co reported "positive" results from its Phase 3 results using Mycapssa for patients with acromegaly (disease where body produces too much hormone).

Daily Premarket watchlist with more information. Check it out at >>
https://www.behindthebid.com/posts/premarket-breakfast-for-tuesday-july-23rd
👍️0
McMahon McMahon 5 years ago
Chiasma management will host a conference call and webcast to discuss the CHIASMA OPTIMAL results in more detail today, July 23, 2019, at 8:30 am EDT.

The dial-in number in the U.S./Canada is 877-407-4018; for international participants, the number is 201-689-8471. For all callers, please refer to Conference ID 13692819.

To access the live webcast, please use the following link: http://public.viavid.com/index.php?id=135476
👍️0
saigai saigai 6 years ago
well made some money from 3-4 dollars and then got distracted chasing elsewhere ..I bought back 850 shares today at 6.45..easy money...should have just stayed put but im here for another ride..
👍️0
whytestocks whytestocks 6 years ago
News: $CHMA Chiasma to Participate in Three Investor Conferences in March

WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases today announced that Mark Fitzpatrick, Chief Executive Officer and William Ludlam, MD...

In case you are interested https://marketwirenews.com/news-releases/chiasma-to-participate-in-three-investor-conferences-in-march-7800548.html
👍️0
saigai saigai 6 years ago
huge volume..a very strange day here
👍️0
saigai saigai 6 years ago
non stop institutional buying..straight line share building...a robert moses special....see you in the teens sooner than later
👍️0
saigai saigai 6 years ago
got 3k shares here and will ad a few more..this is going straight up with a little low volume consolidation here and there...
👍️0
saigai saigai 6 years ago
gonna be a good day ..no one home here
👍️0
gothambio gothambio 7 years ago
Still quiet after another 20%. This is good, no dumb traders involved yet just big funds passively buying. 10 bagger in making
👍️0
gothambio gothambio 7 years ago
surprised so quiet on here. I guess that's good for loading up
👍️0
tripil7z tripil7z 7 years ago
$CHMA long 1000 starter @ 1.35 beat down bio
👍️0
Jumboo Jumboo 8 years ago
Revenue beat !!!
👍️0
Jumboo Jumboo 8 years ago
Trading 44% lower than face value .. Even if the company goes BK .. You will make 44% money . Something doesn't add up here ...
👍️0
Betchips Betchips 8 years ago
Nice pop today, strong move pass the 50 day
👍️0
kany kany 8 years ago
CHMA is very undervalued, considered the Cash/Book above $5. Given a $4 PT for a month or two.
https://www.vetr.com/profile/kan
👍️0
kany kany 8 years ago
CHMA is very undervalued, considered the Cash/Book above $5. Given a $4 PT for a month or two.
https://www.vetr.com/profile/kan
👍️0
Jumboo Jumboo 8 years ago
Difficult chowdhury ji .. I am happy if it goes back to 5
👍️0
Shane Chowdhury Shane Chowdhury 8 years ago
When would we see $10 a share again?
👍️0
blue finch blue finch 8 years ago
Wait it out
Good entry here for a double
But you will have to wait for it
Oversold
👍️0
Jumboo Jumboo 8 years ago
Thoughts here
👍️0
blue finch blue finch 8 years ago
They have plenty of $$
They are meeting the FDA anytime now
After that i expect an update
The drug has marketability
However appears to be a long way off from bringing it forward
I don't know where the real price will be set
To be determined

Good luck

I appreciate your comments on the av&& board thank you
👍️0
XenaLives XenaLives 8 years ago
I have three stocks about to break major so I'm looking for candidates for new positions.

👍️0
blue finch blue finch 8 years ago
Poor management
Unaware more trials required
By FDA
Possible bounce soon


Stay with av@@
This is a long term hold or a trade in a few weeks IMO
👍️0
XenaLives XenaLives 8 years ago
Has anyone done any DD here????

Chart looks interesting, lawsuits are a nice contrarian indicator, what about the tech?

👍️0
gregque gregque 8 years ago
sold my position and bought ensco (esv) @ 9.49 check it out now
👍️0
Jumboo Jumboo 8 years ago
RSI 24... Way over sold .. Bounce is coming
👍️0
Jumboo Jumboo 8 years ago
Time for bounce ... Over sold ...
👍️0
blue finch blue finch 8 years ago
The accumulation phase is almost over
The washout - sellers are done
This should start to retrace soon

Good luck
👍️0
PStockPickz PStockPickz 8 years ago
i have no stake in this myself just looking for a flip but with no volume not going to bother
👍️0
ramalio ramalio 8 years ago
Glad having bought at 8.5 and sold at 10.5 ... rarely so lucky!
👍️0
blue finch blue finch 8 years ago
Check out the seeking alpha piece today
👍️0
PStockPickz PStockPickz 8 years ago
i will wait and see how this looks tomorrow, might grab bottom
👍️0
blue finch blue finch 8 years ago
6 million and counting

Wont see this tomorrow guaranteed
👍️0
blue finch blue finch 8 years ago
Ok here
👍️0
ClearlyStocks ClearlyStocks 8 years ago
Looks tempting, but wouldn't play it unless you are risking $20k or more to sell 5 cent pop. Doubt it flies back I
👍️0

Your Recent History

Delayed Upgrade Clock